v3.25.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities      
Net loss $ (19,342) $ (27,030) $ (64,671)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
Depreciation and amortization expense 13,662 13,811 12,480
Amortization of discount on convertible note 690 1,582 1,976
Amortization of premium on convertible note (1,645) (636) 0
Stock-based compensation expense 23,579 35,377 41,185
Provision for expected credit losses 3,866 3,208 805
Real estate and internal-use software 218 3,533 70
Gain on lease modification 0 (988) 0
Gain on convertible note extinguishment (3,931) (12,110) 0
Other (1,909) (31) 167
Changes in operating assets and liabilities:      
Accounts receivable (5,543) (14,206) (3,877)
Prepaid expenses and other assets (4,630) 6,493 2,063
Deferred commissions 4,870 955 (2,128)
Accounts payable 2,241 (895) 962
Accrued and other liabilities 379 2,843 (25,836)
Deferred revenue 12,986 14,348 12,561
Net cash provided by (used in) operating activities 25,491 26,254 (24,243)
Cash flows from investing activities:      
Cash paid for website domain name (2,444) 0 0
Cash paid for acquisition 0 (100) (7,891)
Purchase of property, equipment, leasehold improvements and capitalized internal-use software (8,598) (3,721) (4,179)
Proceeds from marketable securities 87,276 189,310 243,167
Purchase of marketable securities (92,842) (80,196) (228,281)
Net cash provided by (used in) investing activities (16,608) 105,293 2,816
Cash flows from financing activities:      
Proceeds from exercise of stock options 3,625 1,708 3,849
Taxes paid related to net share settlement of stock options (1,956) (2,449) (3,294)
Holdback payments related to business combination 0 (1,000) 0
Proceeds from financing obligation 0 0 1,081
Payment of convertible note issuance costs (217) (3,176) 0
Repayment of convertible notes and financing obligation (54,528) (109,119) (394)
Net cash provided by (used in) financing activities (53,076) (114,036) 1,242
Net change in cash and cash equivalents and restricted cash (44,193) 17,511 (20,185)
Cash and cash equivalents and restricted cash, beginning of period 90,356 72,845 93,030
Cash and cash equivalents and restricted cash, end of period 46,163 90,356 72,845
Supplemental cash flow information:      
Cash paid for interest 11,174 2,466 894
Noncash investing and financing activities:      
Changes in capital additions, accrued but not paid 1,528 84 168
Fair value of shares issued as consideration for business combinations 0 248 1,417
Right-of-use asset obtained in exchange for new operating lease liability 6,213 0 0
Principal amount of 2028 Convertible Notes exchanged $ 0 $ 150,000 $ 0